Effect of rabeprazole on MDR1-mediated transport of Rhodamine 123 in Caco-2 and Hvr100-6 cells

Biological and Pharmaceutical Bulletin

Volumn 27, Issue 10, 2004, Pages 1694-1696

  Itagaki, Fumio ^a   Homma, Masato ^a   Takara, Kohji ^b   Ohnishi, Noriaki ^b   Yokoyama, Teruyoshi ^b   Sakaeda, Toshiyuki ^c   Yagami, Tatsurou ^d   Kobayashi, Hironao ^d   Okamura, Noboru ^d   Kohda, Yukinao ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

^c KOBE UNIVERSITY   (Japan)

^d SHIONOGI AND CO LTD   (Japan)

Author keywords

Caco 2 cell; Hvr100 6 cell; Inhibitor; MDR1; Rhodamine 123

Indexed keywords

PROTON PUMP INHIBITOR; RABEPRAZOLE; RHODAMINE 123; VINBLASTINE; 2 [[(2 PYRIDYL)METHYL]SULFINYL]BENZIMIDAZOLE DERIVATIVE; BENZIMIDAZOLE DERIVATIVE; DRUG DERIVATIVE; ENZYME INHIBITOR; FLUORESCENT DYE; GLYCOPROTEIN P; OMEPRAZOLE; PROTON PUMP;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD LEVEL; CELL LINE; CELL STRAIN CACO 2; COLON CARCINOMA; CONTROLLED STUDY; HELA CELL; HUMAN; HUMAN CELL; UTERINE CERVIX CARCINOMA; DOSE RESPONSE; DRUG ANTAGONISM; TRANSPORT AT THE CELLULAR LEVEL;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; BENZIMIDAZOLES; BIOLOGICAL TRANSPORT; CACO-2 CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FLUORESCENT DYES; HELA CELLS; HUMANS; OMEPRAZOLE; P-GLYCOPROTEIN; PROTON PUMPS; RHODAMINE 123; VINBLASTINE;

EID: 21644468519     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.27.1694     Document Type: Article

References (11)

1. Lin C. J., Yang J. C., Uang Y. S., Chern H. D., Wang T. H., Pharmacotherapy, 23, 711-719 (2003).
2. Ishizaki T., Horai Y., Aliment. Pharmacol. Ther., 13 (Suppl. 3), 27-36 (1999).
3. Sakai T., Aoyama N., Kita T., Sakaeda T., Nishiguchi K., Nishitora Y., Hohda T., Sirasaka D., Tamura T., Tanigawara Y., Kasuga M., Okumura K., Pharm. Res., 18, 721-727 (2001).
4. Pauli-Magnus C., Rekersbrink S., Klotz U., Fromm M. F., Naunyn-Schmiedeberg's Arch. Pharmacol., 364, 551-557 (2001).
5. Oosterhuis B., Jonkman J. H., Andersson T., Zuderwijk P. B., Jedema J. N., Br. J. Clin. Pharmacol., 32, 569-572 (1991).
6. Takara K., Tsujimoto M., Ohnishi N., Yokoyama T., J. Pharm. Pharmacol., 55, 675-681 (2003).
7. Takara K., Sakaeda T., Tanigawara Y., Nishiguchi K., Ohmoto N., Horinouchi M., Komada F., Ohnishi N., Yokoyama T., Okumura K., Eur. J. Pharm. Sci., 16, 159-165 (2002).
8. Takara K., Tsujimoto M., Ohnishi N., Yokoyama T., Biochem. Biophys. Res. Commun., 292, 190-194 (2002).
9. Lowry O. H., Nira J., Rosebrough A., Farr L., Randall R. J., J. Biol. Chem., 193, 265-275 (1951).
10. Fuhr U., Jetter A., Pharmazie, 57, 595-601 (2002).
11. Homma M., Itagaki F., Yuzawa K., Fukao K., Kohda Y., Transplantation, 73, 303-304 (2002).